
Cefrylan-CV 625 Tablet
Marketer
Osasun Pharma
Salt Composition
Cefuroxime (500mg) + Clavulanic Acid (125mg)
Overview Cefrylan-CV 625 Tablet
Combiflox 625mg tablets combat various bacterial infections by inhibiting microbial proliferation. This prescription medication should be taken exactly as directed. It may be administered with or without food, but consistent timing is crucial for optimal effectiveness. Exceeding the prescribed dosage can be detrimental. If a dose is missed, take it immediately upon recollection. Complete the entire course of treatment, even with symptom improvement; premature cessation may compromise its efficacy. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Consult your physician if side effects worsen. Seek immediate medical attention for allergic reactions (rash, itching, swelling, dyspnea). Inform your doctor of all current medications, especially if you are pregnant, breastfeeding, or have pre-existing health conditions. Alcohol consumption should be avoided due to potential increased drowsiness. While it generally doesn't affect driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and hydration contribute to faster recovery. Your doctor may order blood tests and other diagnostic procedures to monitor the medication's effects.
Primary Ingredients of Cefrylan-CV 625 Tablet
No text provided to rephrase.
Uses of Cefrylan-CV 625 Tablet
Managing Bacterial Infections
Major Benefits of Cefrylan-CV 625 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Cefrylan-CV 625 Tablet whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistent timing is recommended for optimal results.
Common Side effects of Cefrylan-CV 625 Tablet:
- Nausea
- Vomiting
- Diarrhea
- Increased liver enzymes
- Allergic reaction
How to use Cefrylan-CV 625 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Cefrylan-CV 625 Tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, however, consistent timing is recommended.
How Cefrylan-CV 625 Tablet works:
Cefrylan-CV 625 Tablets contain Cefuroxime, an antibiotic, and Clavulanic Acid, a beta-lactamase inhibitor. Cefuroxime combats bacterial infections by disrupting the synthesis of their protective cell walls, hindering their survival. Clavulanic Acid counteracts bacterial enzymes that would otherwise neutralize Cefuroxime, thus broadening Cefuroxime's effectiveness and overcoming bacterial resistance.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Cefrylan-CV 625 Tablet and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The use of Cefrylan-CV 625 Tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences for the fetus; nonetheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
During breastfeeding, Cefrylan-CV 625 Tablet is considered safe. Research in humans indicates negligible transfer of the medication into breast milk, posing no known risk to the infant.
DrivingNOT RELEVANT
Cefrylan-CV 625 Tablet is unsuitable for non-hospitalized individuals.
KidneyCONSULT YOUR DOCTOR
Data regarding Cefrylan-CV 625 Tablet use in patients exhibiting renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Cefrylan-CV 625 Tablet use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Cefrylan-CV 625 Tablet :
Should you forget a Cefrylan-CV 625 Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Cefrylan-CV 625 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
